Five things to watch in markets in the week ahead
NORWELL, Mass. - DIH Holding US, Inc. (NASDAQ:DHAI) received a notice from the Nasdaq Stock Market on September 2 that it had failed to regain compliance with continued listing requirements, according to a company press release. The company’s stock has fallen 83% year-to-date to $0.24, with its market capitalization currently standing at just $12.24 million.
The notice follows DIH’s inability to meet the $50 million market value of listed securities (MVLS) threshold required for continued listing on the Nasdaq Global Market. The company had been given a 180-day compliance period ending September 1, 2025, to address the deficiency first identified on March 5. According to InvestingPro data, the company maintains a Fair financial health rating despite posting negative earnings in the last twelve months.
DIH plans to request a hearing before the Nasdaq Hearing Panel, which will temporarily stay any delisting action for at least 15 days. The company will also seek an extended stay pending the hearing, where it intends to present a compliance plan and request additional time.
The Panel has authority to grant DIH an extension of up to 180 days from the determination for the MVLS requirement and 360 days from the initial filing delinquency.
DIH, a provider of robotic devices used in physical rehabilitation, stated it is "considering all options available to regain compliance" but acknowledged there is no guarantee the Panel will grant its request for continued listing or that the company will be able to demonstrate compliance within any extension period.
The company was formed through mergers of technology providers in the rehabilitation solutions sector.
In other recent news, DIH Holding US, Inc. announced several significant appointments to its leadership and advisory boards. Scott R. Burell, a veteran in healthcare finance, has joined the company’s Board of Directors. Burell is currently the Chief Financial Officer and Secretary of AIVITA Biomedical, and he previously played a pivotal role as CFO at CombiMatrix Corporation during its acquisition by Invitae Corp. Additionally, DIH appointed Dennis Streppa to its Board of Directors, where he will serve as Audit Committee Chair. Streppa brings extensive experience from his tenure as a global Chief Operations Officer, notably at Cardinal Health. Furthermore, Professor Nick Ward, an expert in stroke rehabilitation, has been appointed to DIH’s Scientific Advisory Board. Professor Ward is renowned for his work in upper limb neurorehabilitation at University College London’s Institute of Neurology. These appointments reflect DIH’s strategic efforts to enhance its leadership and advisory capabilities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.